LT3075858T - Žinduolių raiškos vektorius - Google Patents

Žinduolių raiškos vektorius

Info

Publication number
LT3075858T
LT3075858T LTEP16168059.0T LT16168059T LT3075858T LT 3075858 T LT3075858 T LT 3075858T LT 16168059 T LT16168059 T LT 16168059T LT 3075858 T LT3075858 T LT 3075858T
Authority
LT
Lithuania
Prior art keywords
expression vector
mammalian expression
mammalian
vector
expression
Prior art date
Application number
LTEP16168059.0T
Other languages
English (en)
Inventor
Hans-Peter Knopf
Burkhard Wilms
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of LT3075858T publication Critical patent/LT3075858T/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
LTEP16168059.0T 2007-12-21 2008-12-18 Žinduolių raiškos vektorius LT3075858T (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07150339 2007-12-21

Publications (1)

Publication Number Publication Date
LT3075858T true LT3075858T (lt) 2020-04-27

Family

ID=39522442

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP16168059.0T LT3075858T (lt) 2007-12-21 2008-12-18 Žinduolių raiškos vektorius

Country Status (16)

Country Link
US (3) US20110045536A1 (lt)
EP (3) EP3680337A1 (lt)
JP (2) JP5701061B2 (lt)
KR (1) KR101657717B1 (lt)
CN (1) CN101903523B (lt)
AU (1) AU2008339985C1 (lt)
BR (1) BRPI0821311B1 (lt)
CA (1) CA2709894C (lt)
DK (1) DK3075858T3 (lt)
ES (2) ES2585502T3 (lt)
IL (1) IL206170A (lt)
LT (1) LT3075858T (lt)
PL (2) PL2227546T3 (lt)
PT (2) PT3075858T (lt)
RU (1) RU2494147C2 (lt)
WO (1) WO2009080720A1 (lt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101993892A (zh) * 2009-08-31 2011-03-30 长沙赢润生物技术有限公司 肿瘤细胞中靶向性表达shRNA的真核表达载体
KR101868139B1 (ko) * 2010-11-30 2018-06-15 주식회사 엘지화학 새로운 융합 프로모터 및 이를 포함하는 재조합 벡터
US20140227708A1 (en) * 2011-09-16 2014-08-14 Oregon Health & Science University Methods and kits used in identifying microrna targets
EP3378489A1 (en) 2011-10-26 2018-09-26 Elanco Tiergesundheit AG Monoclonal antibodies and methods of use
SI2794878T1 (sl) * 2011-12-22 2020-07-31 F. Hoffmann-La Roche Ag Organizacija ekspresijskega vektorja, postopki izdelave nove proizvodne celice in njihova uporaba za rekombinantno proizvodnjo polipeptidov
DK2922962T3 (en) * 2012-11-20 2017-03-27 Novartis Ag Optimized expression cassette for expressing a high yield polypeptide
JP6392245B2 (ja) 2012-12-18 2018-09-19 ノバルティス アーゲー 遺伝子改変哺乳動物細胞における治療用タンパク質の産生
MY174820A (en) 2012-12-18 2020-05-17 Novartis Ag Stabilized insulin-like growth factor polypeptides
EP2970956A1 (en) 2013-03-11 2016-01-20 Novartis AG Method of screening cell clones
RU2716977C2 (ru) 2013-07-31 2020-03-17 Новартис Аг Новые селективные векторы и способы селекции эукариотических клеток-хозяев
WO2016151599A1 (en) 2015-03-25 2016-09-29 Biogenomics Limited A bigenic mammalian expression vector
UY37758A (es) 2017-06-12 2019-01-31 Novartis Ag Método de fabricación de anticuerpos biespecíficos, anticuerpos biespecíficos y uso terapéutico de dichos anticuerpos
AU2020347945A1 (en) 2019-09-18 2022-03-31 Novartis Ag NKG2D fusion proteins and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017478A (en) * 1987-07-16 1991-05-21 Berlex Laboratories, Inc. Transfected cells containing plasmids having genes oriented in opposing directions and methods of using
EP0555203B1 (en) 1988-12-08 1995-10-18 Abbott Laboratories Expression induction method employing dhfr gene
JPH10506014A (ja) * 1994-09-22 1998-06-16 メルク エンド カンパニー インコーポレーテッド ヒトパピローマウイルス６ａ型をコードするＤＮＡ
US20060246540A1 (en) * 1997-08-26 2006-11-02 Ashkenazi Avi J Secreted and transmembrane polypeptides and nucleic acids encoding the same
CA2385102A1 (en) * 1999-07-12 2001-01-18 Genentech, Inc. Expression vectors and methods
EP2278021A3 (en) * 1999-11-01 2011-05-18 Novartis Vaccines and Diagnostics, Inc. Expression vectors, transfection systems, and method of use thereof
US20040038392A1 (en) 2000-06-08 2004-02-26 Tatsurou Shibui Expression vector enabling screening of cells with high expression of recombinant protein, transformant with high expression of recombinant protein and utilization thereof
DE10256083A1 (de) * 2002-11-29 2004-08-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Expressionsvektor, Verfahren zur Herstellung von heterologen Genprodukten und Selektionsverfahren für hochproduzierende rekombinante Zellen
US7384744B2 (en) * 2002-11-29 2008-06-10 Boehringer Ingelheim Pharma Gmbh & Co., Kg Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such products
US7674618B2 (en) * 2003-09-04 2010-03-09 Medarex, Inc. Expression vector
JP4527010B2 (ja) * 2004-07-20 2010-08-18 日本ブレーキ工業株式会社 ブレーキシューの製造方法
US20060024650A1 (en) 2004-07-30 2006-02-02 Epstein Gerald N Kinesiology-based self-improvement process

Also Published As

Publication number Publication date
IL206170A0 (en) 2010-12-30
KR101657717B1 (ko) 2016-09-19
AU2008339985C1 (en) 2012-12-20
PT3075858T (pt) 2020-04-30
PL3075858T3 (pl) 2020-07-13
JP2011505859A (ja) 2011-03-03
BRPI0821311B1 (pt) 2018-09-18
PL2227546T3 (pl) 2016-11-30
JP5701061B2 (ja) 2015-04-15
CN101903523A (zh) 2010-12-01
AU2008339985A1 (en) 2009-07-02
KR20100109930A (ko) 2010-10-11
WO2009080720A1 (en) 2009-07-02
US20120271040A1 (en) 2012-10-25
PT2227546T (pt) 2016-08-12
AU2008339985B2 (en) 2012-03-01
EP3075858B1 (en) 2020-01-29
ES2585502T3 (es) 2016-10-06
ES2784926T3 (es) 2020-10-02
US9422574B2 (en) 2016-08-23
IL206170A (en) 2016-02-29
RU2010129545A (ru) 2012-01-27
DK3075858T3 (da) 2020-05-04
EP2227546A1 (en) 2010-09-15
EP2227546B1 (en) 2016-05-04
US20110045536A1 (en) 2011-02-24
BRPI0821311A2 (pt) 2014-10-14
USRE49347E1 (en) 2022-12-27
EP3680337A1 (en) 2020-07-15
CN101903523B (zh) 2016-05-18
EP3075858A1 (en) 2016-10-05
CA2709894A1 (en) 2009-07-02
JP2015091238A (ja) 2015-05-14
CA2709894C (en) 2017-10-24
RU2494147C2 (ru) 2013-09-27

Similar Documents

Publication Publication Date Title
IL206170A0 (en) Mammalian expression vector
ZA201004736B (en) Improved mammalian expression vectors and uses thereof
GB0810912D0 (en) Vector
PL2274422T3 (pl) Wektor ekspresyjny
GB0820631D0 (en) Vectors
SI2367943T1 (sl) Sesalski ekspresijski vektor
PL2356241T3 (pl) Wektor sztucznego chromosomu
GB0810154D0 (en) Expression vector
GB0702694D0 (en) Vectors
EP2388321A4 (en) NEW EXPRESSION VECTOR
GB0822289D0 (en) "BABOO"babyseat carry
GB0709375D0 (en) Vector
GB0823425D0 (en) Vectors
GB0609775D0 (en) Vector
GB0716868D0 (en) Easy Carry
GB0705369D0 (en) Easy carry
AU316032S (en) Handbags
AU316027S (en) Handbags
AU316029S (en) Handbags
AU316030S (en) Handbags
AU316031S (en) Handbags
AU316026S (en) Handbags
AU316028S (en) Handbags
GB0806637D0 (en) Culture
GB0806636D0 (en) Culture